Hong Kong Stock Movement | Keymed Biosciences-B (02162.HK) Surges Over 12% as Kangyueda Revenue for the First Three Quarters Increased 227% Year-on-Year and New Indication Approved
Zhito Finance APP has learned that Keymed Biosciences-B (02162.HK) rose over 12%, up 11.82% as of press time, at HK$85.15, with a turnover of HK$89.8682 million.
Latest
